Switching hinges on changing behaviour

15 September 2015 - Deborah Wilkes

Archived

Changing the behaviour of key stakeholders – including consumers, healthcare professionals and regulators – lies at the heart of any successful switch of a medicine from prescription to non-prescription status. Companies should also be prepared to rethink their own behaviour and expectations.

Click tags below for more information on topics:

Maxwellia

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: